Transaction Advisory
Commercial Due Diligence
Reimbursement Due Diligence
Revenue Quality Assessments
Contract Reviews
Investment Thesis Validation
Risk Assessments
Value Creation Planning
Fulcrum Health Partners partners with private equity firms before, during, and after acquisitions to unlock hidden enterprise value — through reimbursement strategy, payer contracting, advanced analytics, operational transformation, managed care leadership, and scalable infrastructure. We don't stop at diligence. We execute.
Healthcare reimbursement is one of the largest — and most underutilized — drivers of enterprise value in healthcare. Fulcrum helps investors identify hidden reimbursement opportunities, quantify their financial impact, execute the improvements, and maximize enterprise value from investment thesis through successful exit.
Unlike traditional consultants who exit after diligence, Fulcrum stays embedded — an extension of the investment team and executive leadership. Select a stage to see where we create value.
Most firms touch one transaction. Fulcrum is present across the entire arc of the investment.
Fulcrum Health Partners — beneath every stage.
Reimbursement is one of the few initiatives that can simultaneously grow revenue, expand EBITDA, improve cash flow, and materially increase enterprise value. Model the impact for a portfolio company.
Adjust the assumptions — results update live.
Illustrative only. Actual outcomes depend on contract terms, payer mix, utilization, implementation, market dynamics, and operational performance.
Because Fulcrum's engagements are project-based and non-recurring, they are frequently treated as EBITDA add-backs in quality-of-earnings analysis at exit — normalized out of run-rate earnings by the buyer's diligence.
Across engaged portfolio companies that have transacted, our fees were treated as add-backs in the substantial majority of deals — so the investment doesn't dilute the multiple, while the reimbursement value we create flows directly into valuation.
Higher normalized EBITDA → a higher exit multiple applied → better ROI for the fund and its shareholders.
Illustrative. Add-back treatment depends on the quality-of-earnings provider, the buyer, and the specific deal terms.
From confidential diligence to embedded execution — the full platform private equity relies on to create and defend value.
Value only counts when it reaches the P&L. We connect contract strategy directly to the revenue cycle so every negotiated dollar is realized.
Provider market heat maps, expected-pay modeling, and value-creation KPIs — the executive views investors use to underwrite and to govern.
Illustrative sample dashboards. Fulcrum Analytics™ is built from real contract, claims, and market data.
We underwrite and create value across the full spectrum of healthcare provider investments.
Our work spans the entire investment lifecycle — not simply one transaction.
Whether evaluating a target, validating a thesis, integrating an acquisition, expanding into new markets, improving portfolio performance, or preparing for exit — Fulcrum helps private equity firms maximize enterprise value through reimbursement, managed care strategy, analytics, and operational execution.